NASDAQ:ACRS
$8.09
(
-2.88%
)
Friday, 31st Mar 2023
Aclaris Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $5.77 | $12.93 | Friday, 31st Mar 2023 ACRS stock ended at $8.09. This is 2.88% less than the trading day before Thursday, 30th Mar 2023. During the day the stock fluctuated 8.58% from a day low at $8.04 to a day high of $8.73. |
| 90 days | $5.77 | $18.54 | |
| 52 weeks | $5.77 | $18.96 |
Historical Aclaris Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2016-06-30 | $18.47 | $18.47 | $18.47 | $18.47 | 47 400 |
| 2016-06-29 | $18.32 | $18.32 | $18.32 | $18.32 | 39 300 |
| 2016-06-28 | $18.07 | $18.07 | $18.07 | $18.07 | 38 200 |
| 2016-06-27 | $17.68 | $17.68 | $17.68 | $17.68 | 105 200 |
| 2016-06-24 | $18.10 | $18.10 | $18.10 | $18.10 | 484 500 |
| 2016-06-23 | $18.21 | $18.21 | $18.21 | $18.21 | 53 500 |
| 2016-06-22 | $18.07 | $18.07 | $18.07 | $18.07 | 76 400 |
| 2016-06-21 | $17.83 | $17.83 | $17.83 | $17.83 | 65 600 |
| 2016-06-20 | $19.13 | $19.13 | $19.13 | $19.13 | 77 200 |
| 2016-06-17 | $18.93 | $18.93 | $18.93 | $18.93 | 245 100 |
| 2016-06-16 | $19.47 | $19.47 | $19.47 | $19.47 | 52 212 |
| 2016-06-15 | $19.20 | $19.20 | $19.20 | $19.20 | 77 961 |
| 2016-06-14 | $19.39 | $19.39 | $19.39 | $19.39 | 86 419 |
| 2016-06-13 | $20.44 | $20.44 | $20.44 | $20.44 | 78 914 |
| 2016-06-10 | $21.97 | $21.97 | $21.97 | $21.97 | 216 711 |
| 2016-06-09 | $21.57 | $21.57 | $21.57 | $21.57 | 89 345 |
| 2016-06-08 | $21.64 | $21.64 | $21.64 | $21.64 | 54 309 |
| 2016-06-07 | $21.91 | $21.91 | $21.91 | $21.91 | 122 700 |
| 2016-06-06 | $22.07 | $22.07 | $22.07 | $22.07 | 216 814 |
| 2016-06-03 | $20.21 | $20.21 | $20.21 | $20.21 | 153 970 |
| 2016-06-02 | $20.94 | $20.94 | $20.94 | $20.94 | 62 458 |
| 2016-06-01 | $20.24 | $20.24 | $20.24 | $20.24 | 79 873 |
| 2016-05-31 | $19.98 | $19.98 | $19.98 | $19.98 | 155 822 |
| 2016-05-27 | $20.00 | $20.00 | $20.00 | $20.00 | 65 415 |
| 2016-05-26 | $19.70 | $19.70 | $19.70 | $19.70 | 18 535 |
| 2016-05-25 | $20.49 | $20.49 | $20.49 | $20.49 | 48 880 |
| 2016-05-24 | $19.80 | $19.80 | $19.80 | $19.80 | 33 175 |
| 2016-05-23 | $19.21 | $19.21 | $19.21 | $19.21 | 79 573 |
| 2016-05-20 | $20.35 | $20.35 | $20.35 | $20.35 | 33 672 |
| 2016-05-19 | $19.79 | $19.79 | $19.79 | $19.79 | 36 591 |
| 2016-05-18 | $19.92 | $19.92 | $19.92 | $19.92 | 39 718 |
| 2016-05-17 | $19.18 | $19.18 | $19.18 | $19.18 | 78 724 |
| 2016-05-16 | $19.19 | $19.19 | $19.19 | $19.19 | 84 301 |
| 2016-05-13 | $19.06 | $19.06 | $19.06 | $19.06 | 149 988 |
| 2016-05-12 | $16.93 | $16.93 | $16.93 | $16.93 | 13 295 |
| 2016-05-11 | $17.97 | $17.97 | $17.97 | $17.97 | 19 491 |
| 2016-05-10 | $19.98 | $19.98 | $19.98 | $19.98 | 34 696 |
| 2016-05-09 | $20.50 | $20.50 | $20.50 | $20.50 | 27 677 |
| 2016-05-06 | $20.71 | $20.71 | $20.71 | $20.71 | 26 760 |
| 2016-05-05 | $21.02 | $21.02 | $21.02 | $21.02 | 29 392 |
| 2016-05-04 | $19.69 | $19.69 | $19.69 | $19.69 | 31 205 |
| 2016-05-03 | $20.63 | $20.63 | $20.63 | $20.63 | 40 552 |
| 2016-05-02 | $20.41 | $20.41 | $20.41 | $20.41 | 27 103 |
| 2016-04-29 | $18.48 | $18.48 | $18.48 | $18.48 | 29 167 |
| 2016-04-28 | $19.76 | $19.76 | $19.76 | $19.76 | 48 530 |
| 2016-04-27 | $20.48 | $20.48 | $20.48 | $20.48 | 30 632 |
| 2016-04-26 | $21.78 | $21.78 | $21.78 | $21.78 | 39 183 |
| 2016-04-25 | $19.68 | $19.68 | $19.68 | $19.68 | 23 005 |
| 2016-04-22 | $19.66 | $19.66 | $19.66 | $19.66 | 34 867 |
| 2016-04-21 | $19.69 | $19.69 | $19.69 | $19.69 | 30 310 |
About Aclaris Therapeutics
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
